Valsartan-hctz 320-25 MG tab 90S
Ended Awarded
- Contract number
- SPE2DB25FD18K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,042
Award facts
- Contract value 100% obligated
- $15,041.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,041.91 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets in quantities of 90 units. This firm fixed-price contract, issued on September 29, 2025, with an ultimate completion date of September 30, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's extensive portfolio of federal contract awards demonstrates its capability to meet diverse pharmaceutical needs, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a child contract under the larger SPE2DX IDC, this delivery order exemplifies the company's role in fulfilling routine pharmaceutical supply requirements for the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FD18K?
SPE2DB25FD18K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FD18K worth?
The government has obligated $15,042 on SPE2DB25FD18K.
Is contract SPE2DB25FD18K an order under another contract?
Yes. SPE2DB25FD18K is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FD18K competed?
The extent of competition for SPE2DB25FD18K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award